Life Science Investor conference
Magnus Corfitzen, Ascelia Pharma's CEO will be presenting at the Life Science Conference at 16:50 CET. Link to this virtual event is: Events - Life Science | Økonomisk Ugebrev
Stockholm Corporate Finance Life Science seminarium
Magnus Corfitzen, Ascelia Pharma's CEO will be presenting at the Stockholm Corporate Finance 13e Life Science seminarium 2021
Stockholm Corporate Finance Life Science seminarium
Magnus Corfitzen, Ascelia Pharma's CEO will be presenting at the Stockholm Corporate Finance 13e Life Science seminarium 2021
HC Andersen Capital och Nordnet: Small & Mid Cap seminarie
Ascelia Pharma’s CEO Magnus Corfitzen presents at HC Andersen Capital och Nordnet: Small & Mid Cap seminarie: Small & Mid Cap Seminar – HC Andersen Capital
HC Andersen Capital och Nordnet: Small & Mid Cap seminarie
Ascelia Pharma’s CEO Magnus Corfitzen presents at HC Andersen Capital och Nordnet: Small & Mid Cap seminarie: Small & Mid Cap Seminar – HC Andersen Capital
HC Andersen Capital Event
Julie Waras Brogren, Chief Commercial Officer at Ascelia Pharma will present at HC Andersen Capital event. The topic will be: 'Mangoral market potential and plans for commercialization’ To register to the event: https://hcandersencapital643.clickmeeting.com/ascelia-pharma-mangoral-markedsstorrelse-og-potentiale/register
HC Andersen Capital Event
Julie Waras Brogren, Chief Commercial Officer at Ascelia Pharma will present at HC Andersen Capital event. The topic will be: 'Mangoral market potential and plans for commercialization’ To register to the event: https://hcandersencapital643.clickmeeting.com/ascelia-pharma-mangoral-markedsstorrelse-og-potentiale/register
Redeye Orphan Drugs Seminar – April 2021
Ascelia Pharma's Chief Medical Officer, Carl Bjartmar will present at Redeye Orphan Drugs Seminar. The presentation will be live streamed, to register to the event: https://www.redeye.se/events/802433/theme-orphan-apr-28th
Redeye Orphan Drugs Seminar – April 2021
Ascelia Pharma's Chief Medical Officer, Carl Bjartmar will present at Redeye Orphan Drugs Seminar. The presentation will be live streamed, to register to the event: https://www.redeye.se/events/802433/theme-orphan-apr-28th
Biotek event with Nordnet dk – 11 May at 10:20
CEO Magnus Corfitzen will present Ascelia Pharma, the event will be live. To register: https://events.nordnet.dk/nordnet-events/kom-helt-taet-paa-tre-biotekvirksomheder-scandion-oncology-ascelia-pharma-hansa-biopharma/
Biotek event with Nordnet dk – 11 May at 10:20
CEO Magnus Corfitzen will present Ascelia Pharma, the event will be live. To register: https://events.nordnet.dk/nordnet-events/kom-helt-taet-paa-tre-biotekvirksomheder-scandion-oncology-ascelia-pharma-hansa-biopharma/
Interim Report Q1 2021 (January-March 2021)
Report will be released at 8.00am CET and conference call at 10:00am CET
Interim Report Q1 2021 (January-March 2021)
Report will be released at 8.00am CET and conference call at 10:00am CET
ABGSC Life Science Summit – Virtual Seminar
Magnus Corfitzen will present at ABGSC Life Science Summit